Simultaneous inactivation of the p16, p15 and p14 genes encoding cyclin-dependent kinase inhibitors in canine T-lymphoid tumor cells

Journal of Veterinary Medical Science

Volumn 75, Issue 6, 2013, Pages 733-742

  Fujiwara Igarashi, Aki ^a   Goto Koshino, Yuko ^a   Mochizuki, Hiroyuki ^a   Maeda, Shingo ^a   Fujino, Yasuhito ^a   Ohno, Koichi ^a   Tsujimoto, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Canine; Lymphoid tumor; P16; Tumor suppressor gene

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA;

AMINO ACID SEQUENCE; ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; GENE EXPRESSION REGULATION; GENETICS; LYMPHOCYTE; LYMPHOMA; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MUTATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CLONING, MOLECULAR; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; DNA, COMPLEMENTARY; DOG DISEASES; DOGS; GENE EXPRESSION REGULATION, NEOPLASTIC; LYMPHOCYTES; LYMPHOMA; MOLECULAR SEQUENCE DATA; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

CANIS FAMILIARIS;

EID: 84879581058     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.12-0351     Document Type: Article

References (45)

1. Aguirre-Hernandez, J., Milne, B. S., Queen, C., O'Brien, P. C., Hoather, T., Haugland, S., Ferguson-Smith, M. A., Dobson, J. M. and Sargan, D. R. 2009. Disruption of chromosome 11 in canine fibrosarcomas highlights an unusual variability of CDKN2B in dogs. BMC Vet. Res. 5: 27. [Medline] [CrossRef]
2. Amara, K., Trimeche, M., Ziadi, S., Laatiri, A., Hachana, M. and Korbi, S. 2008. Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas. Ann. Oncol. 19: 1774-1786. [Medline] [CrossRef]
3. Baur, A. S., Shaw, P., Burri, N., Delacretaz, F., Bosman, F. T. and Chaubert, P. 1999. Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and Tcell lymphomas. Blood 94: 1773-1781. [Medline]
4. Burnett, R. C., Vernau, W., Modiano, J. F., Olver, C. S., Moore, P. F. and Avery, A. C. 2003. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Vet. Pathol. 40: 32-41. [Medline] [CrossRef]
5. Cheung, H. H., Lee, T. L., Rennert, O. M. and Chan, W. Y. 2009. DNA methylation of cancer genome. Birth Defects Res. C Embryo Today 87: 335-350. [Medline] [CrossRef]
6. Chu, L. C., Eberhart, C. G., Grossman, S. A. and Herman, J. G. 2006. Epigenetic silencing of multiple genes in primary CNS lymphoma. Int. J. Cancer 119: 2487-2491. [Medline] [Cross- Ref]
7. DeInnocentes, P., Agarwal, P. and Bird, R. C. 2009. Phenotyperescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer. J. Cell. Biochem. 106: 491-505. [Medline] [CrossRef]
8. Drexler, H. G. 1998. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 12: 845-859. [Medline] [CrossRef]
9. Fosmire, S. P., Thomas, R., Jubala, C. M., Wojcieszyn, J. W., Valli, V. E., Getzy, D. M., Smith, T. L., Gardner, L. A., Ritt, M. G., Bell, J. S., Freeman, K. P., Greenfield, B. E., Lana, S. E., Kisseberth, W. C., Helfand, S. C., Cutter, G. R., Breen, M. and Modiano, J. F. 2007. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma. Vet. Pathol. 44: 467-478. [Medline] [CrossRef]
10. Garcia, M. J., Castrillo, J. M., Granizo, J. J., Cazorla, A. and Rivas, C. 2002. Clinicopathological correlation, p16-p15 methylation status and outcome predictors in anaplastic large cell lymphoma. Br. J. Haematol. 119: 877-878. [Medline] [Cross- Ref]
11. Gil, J. and Peters, G. 2006. Regulation of the INK4b-ARFINK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 7: 667-677. [Medline] [CrossRef]
12. Hahn, K. A., Richardson, R. C., Hahn, E. A. and Chrisman, C. L. 1994. Diagnostic and prognostic importance of chromosomal aberrations identified in 61 dogs with lymphosarcoma. Vet. Pathol. 31: 528-540. [Medline] [CrossRef]
13. Hangaishi, A., Ogawa, S., Imamura, N., Miyawaki, S., Miura, Y., Uike, N., Shimazaki, C., Emi, N., Takeyama, K., Hirosawa, S., Kamada, N., Kobayashi, Y., Takemoto, Y., Kitani, T., Toyama, K., Ohtake, S., Yazaki, Y., Ueda, R. and Hirai, H. 1996. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/ p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood 87: 4949-4958. [Medline]
14. Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S. and Peters, G. 1996. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16: 859-867. [Medline]
15. Hiraoka, H., Minami, K., Kaneko, N., Shimokawa Miyama, T., Okamura, Y., Mizuno, T. and Okuda, M. 2009. Aberrations of the FHIT gene and Fhit protein in canine lymphoma cell lines. J. Vet. Med. Sci. 71: 769-777. [Medline] [CrossRef]
16. Hutter, G., Scheubner, M., Zimmermann, Y., Kalla, J., Katzenberger, T., Hubler, K., Roth, S., Hiddemann, W., Ott, G. and Dreyling, M. 2006. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma. Genes Chromosomes Cancer 45: 203-210. [Medline] [CrossRef]
17. Jardin, F., Jais, J. P., Molina, T. J., Parmentier, F., Picquenot, J. M., Ruminy, P., Tilly, H., Bastard, C., Salles, G. A., Feugier, P., Thieblemont, C., Gisselbrecht, C., De Reynies, A., Coiffier, B., Haioun, C. and Leroy, K. 2010. Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study. Blood 116: 1092-1104. [Medline] [CrossRef]
18. Kees, U. R., Terry, P. A., Ford, J., Everett, J., Murch, A., De Klerk, N. and Baker, D. L. 2005. Detection of hemizygous deletions in genomic DNA from leukaemia specimens for the diagnosis of patients. Leuk. Res. 29: 165-171. [Medline] [CrossRef]
19. Kim, M., Yim, S. H., Cho, N. S., Kang, S. H., Ko, D. H., Oh, B., Kim, T. Y., Min, H. J., She, C. J., Kang, H. J., Shin, H. Y., Ahn, H. S., Yoon, S. S., Kim, B. K., Shin, H. R., Han, K. S., Cho, H. I. and Lee, D. S. 2009. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study. Cancer Genet. Cytogenet. 195: 59-65. [Medline] [CrossRef]
20. Klangby, U., Okan, I., Magnusson, K. P., Wendland, M., Lind, P. and Wiman, K. G. 1998. p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma. Blood 91: 1680-1687. [Medline]
21. Koenig, A., Bianco, S. R., Fosmire, S., Wojcieszyn, J. and Modiano, J. F. 2002. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma. Vet. Pathol. 39: 458-472. [Medline] [CrossRef]
22. Kohno, T., Yamada, Y., Tawara, M., Takasaki, Y., Kamihira, S., Tomonaga, M. and Matsuyama, T. 2007. Inactivation of p14ARF as a key event for the progression of adult T cell leukemia/lymphoma. Leuk. Res. 31: 1625-1632. [Medline] [CrossRef]
23. Krug, U., Ganser, A. and Koeffler, H. P. 2002. Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene 21: 3475-3495. [Medline] [CrossRef]
24. Lee, S. M., Lee, E. J., Ko, Y. H., Lee, S. H., Maeng, L. and Kim, K. M. 2009. Prognostic significance of O6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas. APMIS 117: 87-94. [Medline] [Cross- Ref]
25. Li, J., Poi, M. J. and Tsai, M. D. 2011. Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Biochemistry 50: 5566-5582. [Medline] [CrossRef]
26. Masumoto, N., Fujii, T., Ishikawa, M., Saito, M., Iwata, T., Fukuchi, T., Susumu, N., Mukai, M., Kubushiro, K., Tsukazaki, K. and Nozawa, S. 2003. P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Hum. Pathol. 34: 778-783. [Medline] [CrossRef]
27. Modiano, J. F., Breen, M., Valli, V. E., Wojcieszyn, J. W. and Cutter, G. R. 2007. Predictive value of p16 or Rb inactivation in a model of naturally occurring canine non-Hodgkin's lym phoma. Leukemia 21: 184-187. [Medline] [CrossRef]
28. Momoi, Y., Okai, Y., Watari, T., Goitsuka, R., Tsujimoto, H. and Hasegawa, A. 1997. Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma. Vet. Immunol. Immunopathol. 59: 11-20. [Medline] [CrossRef]
29. Nakaichi, M., Taura, Y., Kanki, M., Mamba, K., Momoi, Y., Tsujimoto, H. and Nakama, S. 1996. Establishment and characterization of a new canine B-cell leukemia cell line. J. Vet. Med. Sci. 58: 469-471. [Medline] [CrossRef]
30. Omura-Minamisawa, M., Diccianni, M. B., Batova, A., Chang, R. C., Bridgeman, L. J., Yu, J., Pullen, J., Bowman, W. P. and Yu, A. L. 2000. Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia. Clin. Cancer Res. 6: 1219-1228. [Medline]
31. Parry, D., Bates, S., Mann, D. J. and Peters, G. 1995. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J. 14: 503-511. [Medline]
32. Popov, N. and Gil, J. 2010. Epigenetic regulation of the INK4b- ARF-INK4a locus: in sickness and in health. Epigenetics 5: 685-690. [Medline] [CrossRef]
33. Russo, A. A., Tong, L., Lee, J. O., Jeffrey, P. D. and Pavletich, N. P. 1998. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395: 237-243. [Medline]
34. Rutgen, B. C., Hammer, S. E., Gerner, W., Christian, M., De Arespacochaga, A. G., Willmann, M., Kleiter, M., Schwendenwein, I. and Saalmuller, A. 2010. Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma. Leuk. Res. 34: 932-938. [Medline] [CrossRef]
35. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D. and Depinho, R. A. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37. [Medline] [CrossRef]
36. Shiozawa, E., Takimoto, M., Makino, R., Adachi, D., Saito, B., Yamochi-Onizuka, T., Yamochi, T., Shimozuma, J., Maeda, T., Kohno, Y., Kawakami, K., Nakamaki, T., Tomoyasu, S., Shiokawa, A. and Ota, H. 2006. Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group. Leuk. Res. 30: 859-867. [Medline] [CrossRef]
37. Starrak, G. S., Berry, C. R., Page, R. L., Johnson, J. L. and Thrall, D. E. 1997. Correlation between thoracic radiographic changes and remission/survival duration in 270 dogs with lymphosarcoma. Vet. Radiol. Ultrasound 38: 411-418. [Medline] [CrossRef]
38. Takasaki, Y., Yamada, Y., Sugahara, K., Hayashi, T., Dateki, N., Harasawa, H., Kawabata, S., Soda, H., Ikeda, S., Tomonaga, M. and Kamihira, S. 2003. Interruption of p16 gene expression in adult T-cell leukaemia/lymphoma: clinical correlation. Br. J. Haematol. 122: 253-259. [Medline] [CrossRef]
39. Taniguchi, T., Chikatsu, N., Takahashi, S., Fujita, A., Uchimaru, K., Asano, S., Fujita, T. and Motokura, T. 1999. Expression of p16INK4A and p14ARF in hematological malignancies. Leukemia 13: 1760-1769. [Medline] [CrossRef]
40. Thomas, R., Seiser, E. L., Motsinger-Reif, A., Borst, L., Valli, V. E., Kelley, K., Suter, S. E., Argyle, D., Burgess, K., Bell, J., Lindblad-Toh, K., Modiano, J. F. and Breen, M. 2011. Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non- Hodgkin lymphomas. Leuk. Lymphoma 52: 1321-1335. [Medline] [CrossRef]
41. Valli, V. E., Vernau, W., De Lorimier, L. P., Graham, P. S. and Moore, P. F. 2006. Canine indolent nodular lymphoma. Vet. Pathol. 43: 241-256. [Medline] [CrossRef]
42. Wong, I. H., Ng, M. H., Huang, D. P. and Lee, J. C. 2000. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications. Blood 95: 1942-1949. [Medline]
43. Yamazaki, J., Baba, K., Goto-Koshino, Y., Setoguchi-Mukai, A., Fujino, Y., Ohno, K. and Tsujimoto, H. 2008. Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction. Vet. Immunol. Immunopathol. 126: 321-331. [Medline] [CrossRef]
44. Zainuddin, N., Kanduri, M., Berglund, M., Lindell, M., Amini, R. M., Roos, G., Sundstrom, C., Enblad, G. and Rosenquist, R. 2011. Quantitative evaluation of p16(INK4a) promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma. Leuk. Res. 35: 438-443. [Medline] [CrossRef]
45. Zindy, F., Quelle, D. E., Roussel, M. F. and Sherr, C. J. 1997. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15: 203-211. [Medline] [CrossRef]